Aspira Women's Health Inc.
AWHL
$0.51
$0.024.51%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -0.78% | 5.85% | 10.28% | 1.80% | -2.73% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.78% | 5.85% | 10.28% | 1.80% | -2.73% |
| Cost of Revenue | -13.17% | -23.43% | -5.60% | -0.88% | 6.48% |
| Gross Profit | 7.95% | 28.50% | 22.15% | 3.67% | -8.32% |
| SG&A Expenses | -45.26% | -23.83% | 2.91% | -5.53% | -6.12% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -38.17% | -19.58% | -7.74% | -5.24% | 0.06% |
| Operating Income | 58.80% | 31.21% | 17.03% | 9.04% | -1.67% |
| Income Before Tax | 24.48% | 59.97% | 55.07% | 24.63% | -52.35% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 24.48% | 59.97% | 55.07% | 24.63% | -52.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 24.48% | 59.97% | 55.07% | 24.63% | -52.35% |
| EBIT | 58.80% | 31.21% | 17.03% | 9.04% | -1.67% |
| EBITDA | 58.80% | 31.06% | 16.62% | 8.71% | -2.30% |
| EPS Basic | 73.40% | 78.05% | 72.04% | 52.18% | -2.25% |
| Normalized Basic EPS | 73.38% | 78.05% | 42.75% | 52.18% | 28.61% |
| EPS Diluted | 73.40% | 78.05% | 72.04% | 52.18% | -2.25% |
| Normalized Diluted EPS | 73.38% | 78.05% | 42.75% | 52.18% | 28.61% |
| Average Basic Shares Outstanding | 184.09% | 82.26% | 60.60% | 57.58% | 49.03% |
| Average Diluted Shares Outstanding | 184.09% | 82.26% | 60.60% | 57.58% | 49.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |